Insights from the expertsRobert Tas, SVP and CMO of Pegasystems, reveals how to gain repeat customers in a market of millennials in True Customer Centricity Requires the Merging of Marketing and IT.
Caitlin Ridge, director of communications at Lattice Engines, explores marketing trends and makes predictions for the upcoming year in I Like Big Stacks and I Cannot Lie.Tomasz Tunguz, venture capitalist at Redpoint Ventures, explains how unicorns define success beyond the $1 billion mark in The Tech Press Cycle And Unicorns.
Peter Boyle of Crazy Egg breaks down why defining your USP could be the most important step you take in How to Dominate Your Industry With an Incredible USP.
Baiyin Zhou of Openview Venture Partners shares how taking risks, surrounding yourself with people who are smarter than you, and loving your business can make your hobby a success
Recent company milestones
Major hires and promotionsRevolution Growth (Washington, D.C.), announced that Kristin Gunther, Ashley Larson, Meredith Balenske, and Chris Hughes have been appointed to VP of various departments (source).
Acquisitions and partnershipsAltran (Paris, France), a global leader in innovation and high-tech engineering consulting, has partnered with Jaguar Land Rover (Coventry, UK), an automotive company, to develop and market a unique and ground-breaking open software platform (source).
Morneau Shepell (Toronto, Ontario), a provider of employee assistance programs, completed the acquisition of Bensinger, DuPont & Associates (Chicago, IL), a leader in problem gambling services, drug testing management and employee assistance programs, to expand their services globally (source).
Freeman (Dallas, TX), a brand experience company, and DoubleDutch (Francisco, CA), a provider of mobile event apps, have partnered to provide personalized technology access to their customers (source).
FundingORIC Pharmaceuticals (San Francisco, CA), a cancer therapy company, raised $53 million in a Series B round led by The Column Group (source).
Surefire Medical (Westminster, CO), a commercial stage company developing a new class of direct-to-tumor delivery systems, raised $15 million in a Series C round led by Tullis Health Investors (source).